# National HealthCare Corporation (NHC) Stock Analysis: A Stable Player in Healthcare with Solid Revenue Growth

- Link: https://www.directorstalkinterviews.com/national-healthcare-corporation-nhc-stock-analysis-a-stable-player-in-healthcare-with-solid-revenue-growth/4121245034
- Published: 2026-03-17T11:15:44+00:00
- Author: Madison Wilson

National HealthCare Corporation (NYSE: NHC) presents an intriguing opportunity for
investors seeking exposure to the healthcare sector, specifically in medical care
facilities. With a market cap of $2.56 billion, NHC offers a comprehensive range
of services through its skilled nursing facilities, assisted and independent living
facilities, homecare and hospice agencies, and health hospitals. Operating since
1971 and based in Murfreesboro, Tennessee, NHC is a seasoned player in the industry,
particularly focusing on the growing demand for elderly care and rehabilitation 
services.

Currently trading at $164.96, NHC’s stock price reflects a modest increase of 0.02%,
with a notable 52-week range from $89.91 to $172.83, indicating a stable yet resilient
performance in a challenging macroeconomic environment. The company’s revenue growth
of 4.60% underscores its ability to adapt and thrive, even as it navigates the complexities
of the healthcare landscape.

One of the standout figures for NHC is its return on equity (ROE) of 11.92%, which
is a testament to its effective management and operational efficiency. Coupled with
an earnings per share (EPS) of 7.67, NHC demonstrates its capacity to deliver consistent
value to shareholders. The company also maintains a healthy free cash flow of $108.38
million, providing it with the flexibility to reinvest in growth opportunities and
sustain its dividend payments.

Speaking of dividends, NHC’s yield stands at 1.55%, with a payout ratio of 32.99%,
ensuring that it returns a portion of its profits to shareholders while retaining
enough capital for future expansion. This solid dividend policy may appeal to income-
focused investors seeking reliable returns.

Despite these positive metrics, it’s noteworthy that NHC currently has no analyst
coverage in terms of buy, hold, or sell ratings, nor is there a target price range
available. This could either suggest a lack of visibility in the investment community
or present an opportunity for astute investors to capitalize on an undervalued asset.

From a technical perspective, NHC’s 50-day moving average of $152.63 and 200-day
moving average of $125.72 highlight a strong upward trend, supported by its relative
strength index (RSI) of 50.27, indicating a balanced market sentiment. The MACD 
of 2.12 against a signal line of 3.04 suggests a neutral momentum, providing a potentially
stable entry point for investors.

In essence, National HealthCare Corporation remains a robust entity within the healthcare
sector, offering a blend of growth and income potential. As demographic shifts continue
to favor increased demand for elderly and rehabilitative care services, NHC is well-
positioned to leverage its comprehensive service offerings. While the absence of
explicit analyst ratings implies a need for investors to conduct their due diligence,
the company’s financial health and strategic positioning make it a compelling consideration
for those seeking a stable investment in healthcare.

Share on: